Humana Beheer

Beheer criteriumcontroles 2/4

De CEO Humana is Jim Rechtin, benoemd in Jan2024, heeft een ambtstermijn van minder dan een jaar. bezit rechtstreeks 0% van de aandelen van het bedrijf, ter waarde € 3.45K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 2.3 jaar en 4 jaar.

Belangrijke informatie

Jim Rechtin

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	less than a year
Eigendom CEO	0.00001%
Management gemiddelde ambtstermijn	2.3yrs
Gemiddelde ambtstermijn bestuur	4yrs

Recente managementupdates

Recent updates

CEO

Jim Rechtin (53 yo)

less than a year

Tenure

Mr. James A. Rechtin, also known as Jim, MBA, served as COO of Humana Inc. since January 08, 2024 until July 01, 2024 and serves as its President since January 08, 2024 and also serves as its Chief Executi...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Susan Diamond	Chief Financial Officer	3.4yrs	US$4.73m	0.0072% € 2.5m
Joseph Ventura	Chief Legal Officer	5.8yrs	US$3.10m	0.0060% € 2.1m
Bruce Broussard	Strategic Advisor	less than a year	US$16.33m	0.073% € 25.3m
George Renaudin	President of Medicare & Medicaid	1.8yrs	US$3.11m	0.0032% € 1.1m
Sanjay Shetty	President of CenterWell	1.7yrs	US$4.58m	0.00014% € 48.3k
James Rechtin	President	less than a year	geen gegevens	0.000010% € 3.4k
John-Paul Felter	Senior VP	2.3yrs	geen gegevens	0.00031% € 106.9k
Eric Tagliere	Senior VP & CTO	less than a year	geen gegevens	geen gegevens
Samir Deshpande	Chief Information Officer	3.8yrs	geen gegevens	0.010% € 3.5m
Timothy Huval	Chief Administrative Officer	5.3yrs	US$3.73m	0.0061% € 2.1m
Lisa Stoner	Vice President of Investor Relations	no data	geen gegevens	geen gegevens
Vishal Agrawal	Chief Strategy & Corporate Development Officer	5.9yrs	geen gegevens	0.0090% € 3.1m

2.3yrs

Gemiddelde duur

51.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van HUM wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.3 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
James Rechtin	President	less than a year	geen gegevens	0.000010% € 3.4k
Kurt Hilzinger	Independent Chairman of the Board	21.3yrs	US$601.30k	0.016% € 5.6m
Karen Katz	Independent Director	5.2yrs	US$346.55k	0.00049% € 168.9k
Frank D'Amelio	Independent Director	21.2yrs	US$363.55k	0.017% € 5.9m
Jorge Mesquita	Independent Director	3.8yrs	US$351.59k	0.0018% € 613.6k
Brad Smith	Independent Director	2.2yrs	US$311.07k	0.00032% € 110.3k
Wayne Frederick	Independent Director	4.8yrs	US$364.87k	0.00037% € 127.5k
David Feinberg	Independent Director	2.7yrs	US$321.52k	0.00037% € 127.5k
Marcy Klevorn	Independent Director	3.8yrs	US$351.94k	0.00036% € 124.1k
John Garratt	Independent Director	4.8yrs	US$326.03k	0.0010% € 358.5k
RaQuel Bono	Independent Director	4.2yrs	US$345.03k	0.00033% € 113.8k
Gordon Smith	Independent Director	less than a year	geen gegevens	geen gegevens

4.0yrs

Gemiddelde duur

62yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van HUM wordt beschouwd als ervaren (gemiddelde ambtstermijn 4 jaar).

Humana Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

Humana Inc. Appoints Michelle O'hara as Chief Human Resources Officer, Effective January 1, 2025

Humana Elects Gordon Smith to Board of Directors

Humana Inc., Annual General Meeting, Apr 18, 2024

Humana Inc., Annual General Meeting, Apr 18, 2024

Humana Inc. Announces Management Changes

Chief Financial Officer recently sold €377k worth of stock

Recent updates

Humana Inc. Appoints Michelle O'hara as Chief Human Resources Officer, Effective January 1, 2025

Humana Inc. Updates Earnings Guidance for the Year Ending December 31, 2024

Third quarter 2024 earnings released: EPS: US$3.99 (vs US$6.74 in 3Q 2023)

Second quarter dividend of US$0.89 announced

Humana Inc. Declares Payment of Quarterly Dividend to Stockholders, Payable on January 31, 2025

Humana Elects Gordon Smith to Board of Directors

New minor risk - Share price stability

Humana Inc. to Report Q3, 2024 Results on Oct 30, 2024

Upcoming dividend of US$0.89 per share

Second quarter dividend of US$0.89 announced

Humana Settles for $90 Million Groundbreaking False Claims Act Case Alleging Medicare Part D Prescription Drug Program Fraud

Humana Inc. Declares Cash Dividend, Payable on October 25, 2024

Humana Inc. Revises Earnings Guidance for the Year Ending December 31, 2024

Humana Inc. to Report Q2, 2024 Results on Jul 31, 2024

Gainey Mckenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Humana, Inc

New minor risk - Profit margin trend

First quarter 2024 earnings released: EPS: US$6.13 (vs US$9.91 in 1Q 2023)

Humana Inc. Revises Earnings Guidance for the Year Ending December 31, 2024

Dividend of US$0.89 announced

Humana Inc. Declares Cash Dividend, Payable on July 26, 2024

Humana Inc. to Report Q1, 2024 Results on Apr 24, 2024

Humana Inc., Annual General Meeting, Apr 18, 2024

Humana Inc., Annual General Meeting, Apr 18, 2024

Humana Inc. Declares Cash Dividend, Payable on April 26, 2024

Humana Inc. Provides Earnings Guidance for 2024

Humana Announces Limited Layoffs

Upcoming dividend of US$0.89 per share at 0.8% yield

Cigna Reportedly Ends Humana Merger Talks

Cigna, Humana Reportedly in Talks for Merger

Humana Inc. Declares Cash Dividend, Payable on January 26, 2024

Third quarter 2023 earnings released: EPS: US$6.74 (vs US$9.44 in 3Q 2022)

Humana Inc. Announces Management Changes

Humana Inc. to Report Q3, 2023 Results on Nov 01, 2023

Humana Inc. (NYSE:HUM) agreed to acquire Senior-focused primary care centers in Texas and Nevada of Cano Health, LLC for $66.7 million.

Upcoming dividend of US$0.89 per share at 0.7% yield

Centerwell Senior Primary Care Introduces In-Home Primary Care

Humana Inc. Declares Cash Dividend, Payable on October 27, 2023

Second quarter 2023 earnings released: EPS: US$7.70 (vs US$5.50 in 2Q 2022)

Humana Inc. Revises Earnings Guidance for the Year Ending December 31, 2023

Humana Inc. to Report Q2, 2023 Results on Aug 02, 2023

Upcoming dividend of US$0.89 per share at 0.8% yield

Investor sentiment deteriorates as stock falls 15%

Chief Financial Officer recently sold €377k worth of stock

First quarter 2023 earnings released: EPS: US$9.91 (vs US$7.33 in 1Q 2022)

Upcoming dividend of US$0.89 per share at 0.7% yield

High number of new directors

Humana Inc. Declares Cash Dividend, Payable on April 28, 2023

Full year 2022 earnings released: EPS: US$22.20 (vs US$22.79 in FY 2021)

Humana Inc. Provides Earnings Guidance for the Fiscal Year Ending December 31, 2023

Humana Inc. to Report Q4, 2022 Results on Feb 01, 2023

Independent Director recently sold €7.1m worth of stock

Upcoming dividend of US$0.79 per share

President recently sold €3.5m worth of stock

Segment President of Retail recently sold €4.1m worth of stock

Third quarter 2022 earnings released: EPS: US$9.44 (vs US$11.91 in 3Q 2021)

Humana Inc. Provides Earning Guidance for Fiscal Year 2022

Humana Inc. Declares Cash Dividend to Stockholders, Payable on January 27, 2023

Humana, USAA Launch New Medicare Advantage Plan Tailored to Veterans’ Needs

Humana Inc. to Report Q3, 2022 Results on Nov 02, 2022

Humana Reportedly Among Firms Looking to Buy Cano Health

Chief Legal Officer recently sold €622k worth of stock

Upcoming dividend of US$0.79 per share

Humana Elects Brad D. Smith to Board of Directors

Humana Inc. Declares Payment of Quarterly Dividend to Stockholders, October 28, 2022

Humana Inc. (NYSE:HUM) agreed to acquire Substantially All of the Assets of Inclusa, Inc.

Second quarter 2022 earnings released: EPS: US$5.50 (vs US$4.57 in 2Q 2021)

Humana Inc. Reports Impairment Charges for the Second Quarter Ended June 30, 2022

Humana Inc. to Report Q2, 2022 Results on Jul 27, 2022

Humana Inc. Announces Management Changes